Class information for:
Level 1: PODOPLANIN//D2 40 ANTIBODY//AGGRUS

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
25370 283 38.3 92%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
296 3       BREAST//BREAST CANCER//LYMPHEDEMA 41323
2107 2             LYMPHANGIOGENESIS//VEGF C//PODOPLANIN 5136
25370 1                   PODOPLANIN//D2 40 ANTIBODY//AGGRUS 283

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PODOPLANIN authKW 7523781 56% 44% 158
2 D2 40 ANTIBODY authKW 485540 2% 75% 6
3 AGGRUS authKW 431594 1% 100% 4
4 AGGRUS PODOPLANIN authKW 323695 1% 100% 3
5 NZ 12 authKW 215797 1% 100% 2
6 RANDAM 2 authKW 215797 1% 100% 2
7 D2 40 authKW 176851 7% 8% 21
8 MOL TUMOR MARKER TEAM address 172633 1% 40% 4
9 D2 40 PODOPLANIN authKW 143863 1% 67% 2
10 PA226 authKW 143863 1% 67% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pathology 1714 22% 0% 63
2 Oncology 1586 39% 0% 111
3 Cell Biology 283 18% 0% 50
4 Dentistry, Oral Surgery & Medicine 120 6% 0% 16
5 Anatomy & Morphology 79 2% 0% 7
6 Medical Laboratory Technology 51 2% 0% 7
7 Biochemistry & Molecular Biology 48 15% 0% 43
8 Dermatology 35 3% 0% 9
9 Medicine, Research & Experimental 29 5% 0% 14
10 Respiratory System 14 2% 0% 7

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MOL TUMOR MARKER TEAM 172633 1% 40% 4
2 ABT ALLGEMEINE EXPT PATHOL 107898 0% 100% 1
3 BRAIN I EMIA REGENERAT 107898 0% 100% 1
4 CHILDRENS MERCY HOSP CLINKANSAS CITY MED 107898 0% 100% 1
5 CHILDRENS MERCY HOSP CLINSECT NEONATOL 107898 0% 100% 1
6 COMPREHENS CANC VIENNA CCC GET 107898 0% 100% 1
7 CRANO IAL DEV ORTHODONT 107898 0% 100% 1
8 CYTHOPATHOS 107898 0% 100% 1
9 GLYCOGENE FUNCT TEAM GLYCOSCI 107898 0% 100% 1
10 GYNECOL DIS PREVENT NUCLEUS NUPREV 107898 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ACTA HISTOCHEMICA ET CYTOCHEMICA 3820 3% 0% 8
2 CANCER SCIENCE 2470 3% 0% 9
3 APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY 1809 2% 0% 5
4 JOURNAL OF ORAL SCIENCE 1500 1% 1% 2
5 ADVANCES IN ANATOMIC PATHOLOGY 675 1% 0% 2
6 ORAL ONCOLOGY 566 1% 0% 4
7 MOLECULAR CANCER 544 1% 0% 3
8 AMERICAN JOURNAL OF CANCER RESEARCH 544 1% 0% 2
9 CANCER GENOMICS & PROTEOMICS 512 0% 0% 1
10 JOURNAL OF ORAL PATHOLOGY & MEDICINE 498 1% 0% 4

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 PODOPLANIN 7523781 56% 44% 158 Search PODOPLANIN Search PODOPLANIN
2 D2 40 ANTIBODY 485540 2% 75% 6 Search D2+40+ANTIBODY Search D2+40+ANTIBODY
3 AGGRUS 431594 1% 100% 4 Search AGGRUS Search AGGRUS
4 AGGRUS PODOPLANIN 323695 1% 100% 3 Search AGGRUS+PODOPLANIN Search AGGRUS+PODOPLANIN
5 NZ 12 215797 1% 100% 2 Search NZ+12 Search NZ+12
6 RANDAM 2 215797 1% 100% 2 Search RANDAM+2 Search RANDAM+2
7 D2 40 176851 7% 8% 21 Search D2+40 Search D2+40
8 D2 40 PODOPLANIN 143863 1% 67% 2 Search D2+40+PODOPLANIN Search D2+40+PODOPLANIN
9 PA226 143863 1% 67% 2 Search PA226 Search PA226
10 YM 1 143863 1% 67% 2 Search YM+1 Search YM+1

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 DANG, Q , LIU, J , LI, J , SUN, YP , (2014) PODOPLANIN: A NOVEL REGULATOR OF TUMOR INVASION AND METASTASIS.MEDICAL ONCOLOGY. VOL. 31. ISSUE 9. P. - 44 75% 12
2 UGORSKI, M , DZIEGIEL, P , SUCHANSKI, J , (2016) PODOPLANIN - A SMALL GLYCOPROTEIN WITH MANY FACES.AMERICAN JOURNAL OF CANCER RESEARCH. VOL. 6. ISSUE 2. P. 370 -386 62 54% 0
3 SWAIN, N , KUMAR, SV , ROUTRAY, S , PATHAK, J , PATEL, S , (2014) PODOPLANIN-A NOVEL MARKER IN ORAL CARCINOGENESIS.TUMOR BIOLOGY. VOL. 35. ISSUE 9. P. 8407 -8413 44 76% 5
4 PULA, B , WITKIEWICZ, W , DZIEGIEL, P , PODHORSKA-OKOLOW, M , (2013) SIGNIFICANCE OF PODOPLANIN EXPRESSION IN CANCER-ASSOCIATED FIBROBLASTS: A COMPREHENSIVE REVIEW.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 42. ISSUE 6. P. 1849-1857 55 50% 9
5 CHUANG, WY , YEH, CJ , CHAO, YK , LIU, YH , CHANG, YS , TSENG, CK , CHANG, HK , WAN, YL , HSUEH, C , (2014) CONCORDANT PODOPLANIN EXPRESSION IN CANCER-ASSOCIATED FIBROBLASTS AND TUMOR CELLS IS AN ADVERSE PROGNOSTIC FACTOR IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. VOL. 7. ISSUE 8. P. 4847 -4856 31 79% 3
6 KATO, Y , KUNITA, A , ABE, S , OGASAWARA, S , FUJII, Y , OKI, H , FUKAYAMA, M , NISHIOKA, Y , KANEKO, MK , (2015) THE CHIMERIC ANTIBODY CHLPMAB-7 TARGETING HUMAN PODOPLANIN SUPPRESSES PULMONARY METASTASIS VIA ADCC AND CDC RATHER THAN VIA ITS NEUTRALIZING ACTIVITY.ONCOTARGET. VOL. 6. ISSUE 34. P. 36003 -36018 32 74% 1
7 KATO, Y , OGASAWARA, S , OKI, H , GOICHBERG, P , HONMA, R , FUJII, Y , KANEKO, MK , (2016) LPMAB-12 ESTABLISHED BY CASMAB TECHNOLOGY SPECIFICALLY DETECTS SIALYLATED O-GLYCAN ON THR52 OF PLATELET AGGREGATION-STIMULATING DOMAIN OF HUMAN PODOPLANIN.PLOS ONE. VOL. 11. ISSUE 3. P. - 24 89% 0
8 OCHOA-ALVAREZ, JA , KRISHNAN, H , PASTORINO, JG , NEVEL, E , KEPHART, D , LEE, JJ , RETZBACH, EP , SHEN, Y , FATAHZADEH, M , BAREDES, S , ET AL (2015) ANTIBODY AND LECTIN TARGET PODOPLANIN TO INHIBIT ORAL SQUAMOUS CARCINOMA CELL MIGRATION AND VIABILITY BY DISTINCT MECHANISMS.ONCOTARGET. VOL. 6. ISSUE 11. P. 9045 -9060 43 44% 6
9 INOUE, H , TSUCHIYA, H , MIYAZAKI, Y , KIKUCHI, K , IDE, F , SAKASHITA, H , KUSAMA, K , (2014) PODOPLANIN EXPRESSING CANCER-ASSOCIATED FIBROBLASTS IN ORAL CANCER.TUMOR BIOLOGY. VOL. 35. ISSUE 11. P. 11345 -11352 30 68% 4
10 KRISHNAN, H , RETZBACH, EP , RAMIREZ, MI , LIU, T , LI, H , MILLER, WT , GOLDBERG, GS , (2015) PKA AND CDK5 CAN PHOSPHORYLATE SPECIFIC SERINES ON THE INTRACELLULAR DOMAIN OF PODOPLANIN (PDPN) TO INHIBIT CELL MOTILITY.EXPERIMENTAL CELL RESEARCH. VOL. 335. ISSUE 1. P. 115 -122 30 67% 0

Classes with closest relation at Level 1


Rank Class id link
1 1435 LYMPHANGIOGENESIS//VEGF C//VEGFR 3
2 27092 OCCULT NEOPLASTIC CELLS//FIBROTIC FOCUS//OISO HOSP
3 7275 CANCER ASSOCIATED FIBROBLASTS//JEFFERSON STEM CELL BIOL REGENERAT MED//MANCHESTER BREAST
4 16983 THROMBOCYTOSIS//SERUM FIBRINOGEN//PREOPERATIVE PLATELET COUNT
5 14294 PHOSPHATIDYLCHOLINE SECRETION//TYPE II PNEUMOCYTE//SURFACTANT SECRETION
6 4132 GLYCOPROTEIN VI//GPVI//PLATELETS
7 12187 CANCER PROCOAGULANT//TUMOR PROCOAGULANT//CANCER CELL DERIVED BLOOD COAGULATING ACTIVITY 1
8 36294 EBP1//ERBB3 BINDING PROTEIN 1//PA2G4
9 6782 MESOTHELIOMA//MALIGNANT MESOTHELIOMA//WELL DIFFERENTIATED PAPILLARY MESOTHELIOMA
10 15024 FIBROBLASTIC RETICULAR CELLS//INTRAVITAL IMAGING//LYMPHOCYTE BIOL SECT

Go to start page